Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Acquired by Congress Asset Management Co. MA

Congress Asset Management Co. MA grew its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 596.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 679,256 shares of the company’s stock after purchasing an additional 581,685 shares during the quarter. Congress Asset Management Co. MA’s holdings in Prestige Consumer Healthcare were worth $41,584,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of PBH. Pacer Advisors Inc. boosted its position in Prestige Consumer Healthcare by 85.7% during the fourth quarter. Pacer Advisors Inc. now owns 442 shares of the company’s stock worth $27,000 after acquiring an additional 204 shares during the last quarter. Parallel Advisors LLC boosted its position in Prestige Consumer Healthcare by 42.5% during the fourth quarter. Parallel Advisors LLC now owns 714 shares of the company’s stock worth $44,000 after acquiring an additional 213 shares during the last quarter. M&T Bank Corp boosted its position in Prestige Consumer Healthcare by 7.5% during the fourth quarter. M&T Bank Corp now owns 4,139 shares of the company’s stock worth $253,000 after acquiring an additional 289 shares during the last quarter. Quadrant Capital Group LLC boosted its position in Prestige Consumer Healthcare by 29.3% during the fourth quarter. Quadrant Capital Group LLC now owns 1,660 shares of the company’s stock worth $102,000 after acquiring an additional 376 shares during the last quarter. Finally, GAMMA Investing LLC acquired a new stake in Prestige Consumer Healthcare during the fourth quarter worth approximately $25,000. 99.95% of the stock is currently owned by institutional investors and hedge funds.

Prestige Consumer Healthcare Trading Down 0.9 %

NYSE:PBH traded down $0.59 during trading hours on Friday, reaching $64.25. 206,530 shares of the company were exchanged, compared to its average volume of 249,041. The company has a debt-to-equity ratio of 0.68, a current ratio of 3.20 and a quick ratio of 2.02. The firm has a market cap of $3.21 billion, a price-to-earnings ratio of 15.41, a PEG ratio of 1.82 and a beta of 0.50. Prestige Consumer Healthcare Inc. has a 52-week low of $56.25 and a 52-week high of $75.31. The stock has a 50 day simple moving average of $67.46 and a 200 day simple moving average of $66.16.

Prestige Consumer Healthcare (NYSE:PBH) last issued its earnings results on Tuesday, May 14th. The company reported $1.02 EPS for the quarter, missing analysts’ consensus estimates of $1.14 by ($0.12). Prestige Consumer Healthcare had a net margin of 18.60% and a return on equity of 13.48%. The business had revenue of $277.00 million during the quarter, compared to analysts’ expectations of $287.42 million. During the same period in the prior year, the business posted $1.07 EPS. The business’s revenue was down 3.1% on a year-over-year basis. As a group, analysts predict that Prestige Consumer Healthcare Inc. will post 4.42 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on PBH shares. StockNews.com lowered shares of Prestige Consumer Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, May 21st. Canaccord Genuity Group reaffirmed a “buy” rating and set a $80.00 price target on shares of Prestige Consumer Healthcare in a research note on Tuesday, May 21st. Finally, DA Davidson reaffirmed a “neutral” rating and set a $65.00 price target on shares of Prestige Consumer Healthcare in a research note on Thursday, May 16th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $91.25.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.